RituximabExacerbation of multiple sclerosis in the form of tumefactive demyelinating lesions: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1864卷 / 1期
关键词：
D O I：
10.1007/s40278-021-99261-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：336 / 336
相关论文
共 50 条
  • [21] Alemtuzumab/FingolimodRebound effect in the form of tumefactive multiple sclerosis : case report
    Reactions Weekly, 2024, 2019 (1) : 24 - 24
  • [22] FingolimodReactivation of multiple sclerosis with tumefactive lesions and rebound effect: case report
    Reactions Weekly, 2014, 1519 (1) : 81 - 81
  • [23] Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers
    Rabaneda-Lombarte, Neus
    Teniente-Serra, Aina
    Massuet-Vilamajo, Anna
    Ramo-Tello, Cristina
    Presas-Rodriguez, Silvia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Neuroimaging features of tumefactive demyelinating lesions: A rare case report
    Febyan
    Sutrisno, Sony
    Ronny
    Wetarini, Krisnhaliani
    EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2020, 7
  • [25] Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis
    Totaro, Rocco
    Di Carmine, C.
    Splendiani, A.
    Torlone, S.
    Patriarca, L.
    Carrocci, C.
    Sciamanna, S.
    Marini, C.
    Carolei, A.
    NEUROLOGICAL SCIENCES, 2016, 37 (07) : 1113 - 1117
  • [26] Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology
    Saridas, Furkan
    Mesut, Gizem
    Ceylan, Ceren Yayla
    Ozpar, Rifat
    Ozsen, Mine
    Koc, Emine Rabia
    Tolunay, Sahsine
    Hakyemez, Bahattin
    Turan, Omer Faruk
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 85
  • [27] Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis
    Rocco Totaro
    C. Di Carmine
    A. Splendiani
    S. Torlone
    L. Patriarca
    C. Carrocci
    S. Sciamanna
    C. Marini
    A. Carolei
    Neurological Sciences, 2016, 37 : 1113 - 1117
  • [28] Intraarterial melphalan as targeted therapy for tumefactive multiple sclerosis lesions: a case report
    Banks, Samantha
    Brinjikji, Waleed
    Giannini, Caterina
    Syc-Mazurek, Stephanie
    Xeros, Helena
    Toledano, Michel
    Mustafa, Rafid
    Carabenciov, Ivan Darin
    Tobin, Oliver
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1006 - 1007
  • [29] Case Report of Two Tumefactive Demyelinating Lesions Mimicking Brain Tumor
    Choi, Eu-Jene
    Lee, Su-Jin
    Kim, Young-Do
    Maeng, Lee-So
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 831 - 831
  • [30] Tumefactive demyelinating lesions under fingolimod. A tunisian case report
    Ghariani, A.
    Sakka, S.
    Moalla, K. S.
    Farhat, N.
    Damak, M.
    Mhiri, C.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 317 - 317
12345